Skip to main content

Want a detailed portfolio tracker?

Cassava Sciences (SAVA) P/E

Cassava Sciences (SAVA) P/E from May 28, 2026 to Jul 21, 2026. The TTM Cassava Sciences (SAVA) P/E is -1.48. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cassava Sciences (SAVA)

YearP/EChange
2026-1.48N/A

Comparison Cassava Sciences (SAVA) P/E with competitors

Cassava Sciences (SAVA) P/E is -1.48.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.29%
ENLVEnlivex Ltd0.07-105.07%
FGENFibroGen Inc0.24-116.26%
CHRSCoherus Biosciences Inc0.85-157.49%
FBIOFortress Biotech Inc0.95-164.30%
ORMPOramed Pharmaceuticals Inc1.50-201.84%
AGENAgenus Inc3.01-303.91%
INVAInnoviva Inc3.15-313.69%
VXRTVaxart Inc3.55-340.50%
CRMDCorMedix Inc3.63-345.84%
CVACCureVac N.V.4.45-401.21%
GLPGGalapagos NV4.86-429.20%
SRPTSarepta Therapeutics Inc4.88-430.77%
ABEOAbeona Therapeutics Inc5.39-465.02%
ABUSArbutus Biopharma Corp5.60-479.12%
ZVRAZevra Therapeutics Inc5.89-498.87%
SPROSpero Therapeutics Inc6.23-521.99%
CGENCompugen Ltd6.31-527.79%
RIGLRigel Pharmaceuticals6.87-565.60%
SLXNSilexion Therapeutics Corp7.30-594.33%
OMEROmeros Corporation9.26-727.30%
AUPHAurinia Pharmaceuticals Inc9.58-749.41%
PLXProtalix BioTherapeutics Inc10.89-837.89%
ACADAcadia Pharmaceuticals Inc11.73-894.64%
TBPHTheravance Biopharma Inc12.26-930.79%
ADMAAdma Biologics Inc12.42-941.36%
HRMYHarmony Biosciences Holdings Inc13.82-1036.36%
SABSSAB Biotherapeutics Inc14.14-1057.77%
NAGENiagen Bioscience Inc14.82-1103.97%
INCYIncyte Corp15.82-1172.02%
REGNRegeneron Pharmaceuticals Inc15.86-1174.33%
PBYIPuma Biotechnology Inc17.32-1273.19%
CPRXCatalyst Pharmaceuticals Inc17.44-1281.56%
EXELExelixis Inc17.54-1288.25%
TGTXTG Therapeutics Inc18.97-1385.00%
MDXGMimedx Group Inc20.55-1492.49%
XOMAXOMA Royalty Corp22.87-1649.87%
ARGXArgen X SE24.30-1746.30%
CTMXCytomX Therapeutics Inc24.82-1781.74%
XOMAOXOMA Royalty Corp25.34-1817.23%
HALOHalozyme Therapeutics Inc25.62-1836.12%
XOMAPXOMA Royalty Corp25.67-1839.27%
VRTXVertex Pharmaceuticals Inc27.99-1996.77%
RPRXRoyalty Pharma plc - Class A28.69-2043.71%
SLNOSoleno Therapeutics Inc29.02-2065.92%
ASNDAscendis Pharma A/S30.09-2138.43%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2668.71%
APLSApellis Pharmaceuticals Inc39.02-2743.87%
BMRNBiomarin Pharmaceutical Inc42.21-2960.05%
KRYSKrystal Biotech Inc45.34-3172.23%
ONCBeiGene Ltd69.54-4811.69%
PHARPharming Group N.V.75.03-5183.33%
TECHBio-Techne Corp101.96-7008.15%
VCELVericel Corp109.92-7547.68%
ALNYAlnylam Pharmaceuticals Inc117.96-8092.68%
GMABGenmab140.29-9605.35%
TLXTelix Pharmaceuticals Ltd162.15-11086.61%
CORTCorcept Therapeutics Inc212.86-14522.09%